Shilpa Medicare Limited (full production cycle; quality control for 'Impurities' parameter; quality control and stability testing (physical and chemical tests))

The drug is used to treat adult patients with chronic myeloid leukemia (CML) that has the Philadelphia chromosome. It is prescribed both at the initial diagnosis of the chronic phase of the disease and in cases where previous therapy (e.g., imatinib) has been ineffective or not tolerated.

Dosage form: capsules, hard

ATC: L01EA03

The drug is used to treat adults with chronic myeloid leukemia (Ph+ CML) in the chronic phase. It is also prescribed in the chronic or accelerated phase if previous therapy (e.g., imatinib) was ineffective or unsuitable for the patient.

Dosage form: capsules, hard

ATC: L01EA03